In the rapidly evolving landscape of precision medicine, the success of a therapy is often closely entwined with the effectiveness of its companion diagnostic (CDx). The journey to this success begins with a counterintuitive yet strategic step — start with the end in mind.
In this webinar, attendees will gain insights into how they can evaluate potential companion diagnostic partners not just for their development skills but for their proven ability to commercialize assays effectively, including:
The presence of a robust infrastructure for market penetration
The ability to navigate the complex web of regulatory and reimbursement environments
Establishing channels for educating physicians to drive awareness and adoption of new CDx tests
An integrated system that facilitates ease of ordering and sample collection